Oncodesign Precision Medicine SA News - ALOPM

Oncodesign Precision Medicine obtient des subventions FEDER d’un montant total de 2,1 M€ pour son programme COMETE

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (ALOPM), entreprise biopharmaceutique spécialisée...

Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (Paris:ALOPM), entreprise biopharmaceutique...

TP ICAP Midcap initie à l’achat la couverture d’Oncodesign Precision Medicine

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (Paris:ALOPM), entreprise biopharmaceutique...

Oncodesign Precision Medicine Announces a 6 Million Euros Bank Financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale

This non-dilutive financing enables OPM to continue the clinical development of OPM-101 and to support the development of its products portfolio...

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

Completion of the single-dose administration (SDA) part of the Phase 1 healthy volunteers study of OPM-101 and transition to the multiple-dose...

OPM met à disposition son rapport financier du 1er semestre 2023

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en...

OPM Announces Its Results for the First Half of 2023

One Year After Its Creation, OPM Continues to Successfully Complete the Clinical Development of Its Drug Candidate OPM 101 and Its Technological...

Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en...

Oncodesign Precision Medicine: Report of the annual General Meeting of 30 May 2023

Nomination of Florence Dupré as a member of the Board of Directors Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63;...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Oncodesign Precision Medicine SA (ALOPM)

Empower your portfolio: Real-time discussions and actionable trading ideas.

ALOPM News

Oncodesign Precision Medicine obtient des subventions FEDER d’un montant total de 2,1 M€ pour son programme COMETE

Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

TP ICAP Midcap initie à l’achat la couverture d’Oncodesign Precision Medicine

Oncodesign Precision Medicine Announces a 6 Million Euros Bank Financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

OPM met à disposition son rapport financier du 1er semestre 2023

OPM Announces Its Results for the First Half of 2023

Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

Oncodesign Precision Medicine: Report of the annual General Meeting of 30 May 2023

ALOPM Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Oncodesign Precision Medicine SA (ALOPM) News

Oncodesign Precision Medicine SA (ALOPM)

Empower your portfolio: Real-time discussions and actionable trading ideas.

ALOPM News

Oncodesign Precision Medicine obtient des subventions FEDER d’un montant total de 2,1 M€ pour son programme COMETE

Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

TP ICAP Midcap initie à l’achat la couverture d’Oncodesign Precision Medicine

Oncodesign Precision Medicine Announces a 6 Million Euros Bank Financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

OPM met à disposition son rapport financier du 1er semestre 2023

OPM Announces Its Results for the First Half of 2023

Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

Oncodesign Precision Medicine: Report of the annual General Meeting of 30 May 2023

ALOPM Discussion

Your Recent History